Medical Advisory Board

From its inception, the Lung Cancer Research Foundation has been privileged to have a Medical Advisory Board comprised of renowned, multi-disciplinary scientists and physicians whose expertise spans all lung cancer specialties. Each board member is affiliated with a major cancer center and can apply his or her knowledge to identifying cutting-edge proposals that in future years will make major contributions toward the prevention and treatment of lung cancer.

Julie Brahmer, MD

Interim Director, Sidney Kimmel Comprehensive Cancer (Johns Hopkins Bayview Campus)
Associate Professor of Oncology
Johns Hopkins University Medical School

Roy Herbst, MD, PhD

Professor of Medicine and Pharmacology
Chief of Medical Oncology
Director, Thoracic Oncology Research Program
Associate Director for Translational Research
Translational Research Program
Yale Comprehensive Cancer Center
Yale School of Medicine

Donald W. Kufe, MD

Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School

Marc Ladanyi, MD

Director, Laboratory of Diagnostic Molecular Pathology
Memorial Sloan-Kettering Cancer Center

Jack A. Roth, MD

Chief, Section of Thoracic Molecular Oncology
Professor, Department of Thoracic and Cardiovascular Surgery
The University of Texas MD Anderson Cancer Center

Charles M. Rudin, MD, PhD

Chief of Thoracic Oncology Service
Memorial Sloan Kettering

Brendon Stiles, MD

Assistant Professor of Cardiothoracic Surgery
Weill Cornell Medical College, New York-Presbyterian Hospital

Ralph R. Weichselbaum, MD

Chairman, Department of Radiation and Cellular Oncology
Director, Ludwig Center for Metastasis Research
University of Chicago Comprehensive Cancer Center
University of Chicago Medical School

James B. Dougherty, MD (Chair)

Medical and Scientific Advisor, LCRF Board of Directors
General Partner, Arcus Ventures Fund